 |
市場調查報告書
商品編碼
2052660
虛擬臨床試驗市場：依研究類型、階段、雇主規模、治療領域及地區分類Virtual Clinical Trials Market, By Study Type, By Phases, By Company Size, By Therapeutic Area, and By Geography |
||||||
價格
簡介目錄
預計到 2026 年，虛擬臨床試驗市場規模將達到 43.392 億美元，到 2033 年將達到 137 億美元。預計從 2026 年到 2033 年，該市場將以 17.9% 的複合年成長率成長，達到 137 億美元。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 43.392億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 17.90% | 2033年市場規模預測： | 137億美元 |
虛擬臨床試驗是一種相對較新的臨床研究方法，它利用技術和線上社交互動平台。虛擬臨床試驗有望顯著推動臨床調查方法的數位轉型，並建立以患者為中心的生態系統。它透過數位技術最佳化臨床試驗流程。
市場動態
疾病負擔加重、虛擬臨床試驗的普及、遠端醫療的日益滲透、新技術的日益普及、醫療保健數位化進程的推進、技術進步以及 COVID-19（疫情）的爆發，預計將成為預測期內推動全球虛擬臨床試驗市場成長的關鍵因素。
例如，2019年11月，強生公司與PRA Health Sciences合作啟動了「CHIEF-HF」項目，這是一項完全去中心化的行動臨床試驗，旨在拓展卡格列淨的適應症。該公司計劃利用穿戴式裝置和智慧技術，有效地收集和分析證據，以評估Canagliflozin在普通心臟衰竭患者（無論是否患有第2型糖尿病）的療效。
本次調查的主要特點
- 本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本研究根據公司亮點、產品系列、主要特點、財務績效和策略等參數，對全球虛擬臨床試驗市場的主要參與者進行了分析。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份全球虛擬臨床試驗市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過分析全球虛擬臨床試驗市場時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 全球虛擬臨床試驗的興起
- 與虛擬臨床試驗相關的問題
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
第4章 全球虛擬臨床試驗市場：依研究類型分類，2021-2033年
- 干預試驗
- 其他
第5章 全球虛擬臨床試驗市場：依階段分類，2021-2033年
- 後期
- 初期
第6章 全球虛擬臨床試驗市場：依公司規模分類，2021-2033年
- 小型和中型
- 大型公司
第7章 全球虛擬臨床試驗市場：依治療領域分類，2021-2033年
- 腫瘤學
- 罕見疾病和遺傳疾病
- 中樞神經系統（CNS）
- 免疫學
- 其他
第8章 全球虛擬臨床試驗市場：依地區分類，2021-2033年
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東和非洲
第9章 競爭情勢
- Delve Health
- Clario
- Clinical Ink
- Castor
- Accenture
- Thread
- Science 37
- Medable
- Dassault Systemes
- eElinicalHealth（CLINPAL）
第10章
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI5658
Virtual Clinical Trials Market is estimated to be valued at USD 4,339.2 Mn in 2026 and is expected to reach USD 13,700.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 17.9%USD 13,700.0 Mn from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4,339.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.90% | 2033 Value Projection: | USD 13,700 Mn |
Virtual clinical trials is a relatively new method of conducting clinical research using technologies and online social engagement platforms. Virtual trials have the potential to drive significant digital alterations in the clinical research methodologies to create an improved patient-centric ecosystem. Virtual clinical trials are digitally empowered the clinical trial process.
Market Dynamics
Growing burden of diseases, spike in virtual clinical trials adoption, rise in adoption of telehealth, rise in adoption of novel technologies, rise in healthcare digitization, technological advancements, and the outbreak of COVID-19 (pandemic) are major factors expected to boost the growth of the global virtual clinical trials market during the forecast period.
For instance, in November 2019, Johnson & Johnson in collaboration with PRA Health Sciences, launched the clinical trial set-up CHIEF-HF, a completely decentralize, indication-seeking, mobile clinical study. The company aims to utilize wearable devices and smart technology to efficiently gather and analyze evidence for assessing effectiveness of Canagliflozin in the populace with heart failure with presence of absence of type 2 diabetes.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global virtual clinical trials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Delve Health, Clario, Clinical Ink, Castor, Accenture, Thread, Science 37, Medable, Dassault Systemes, and eElinicalHealth (CLINPAL), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global virtual clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virtual clinical trials market.
Market Segmentation
- Global Virtual Clinical Trials Market, By Study Type (Revenue, USD Mn, 2021 - 2033)
- Interventional
- Others
- Global Virtual Clinical Trials Market, By Phases (Revenue, USD Mn, 2021 - 2033)
- Late Stage
- Early Stage
- Global Virtual Clinical Trials Market, By Company Size (Revenue, USD Mn, 2021 - 2033)
- Small- & Mid-sized
- Large-sized
- Global Virtual Clinical Trials Market, By Therapeutic Area (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Rare & Genetic Diseases
- CNS
- Immunology
- Others
- Global Virtual Clinical Trials Market, By Geography (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Delve Health
- Clario
- Clinical Ink
- Castor
- Accenture
- Thread
- Science 37
- Medable
- Dassault Systemes
- eElinicalHealth (CLINPAL)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Study Type
- Market Snapshot, By Phases
- Market Snapshot, By Company Size
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increase in number of virtual clinical trials worldwide
- Challenges associated with virtual clinical trials
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Virtual Clinical Trials Market, By Study Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Interventional
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Virtual Clinical Trials Market, By Phases, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Late Stage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Early Stage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Virtual Clinical Trials Market, By Company Size, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Small- & Mid-sized
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Large-sized
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Virtual Clinical Trials Market, By Therapeutic Area, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Rare & Genetic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- CNS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Virtual Clinical Trials Market, By Geography, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Delve Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Clario
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Clinical Ink
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Castor
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Accenture
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thread
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Science 37
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medable
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dassault Systemes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- eElinicalHealth (CLINPAL)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
